Top compounds associated with response to RAD9B


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC 0.17 0.001
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA etoposide CTRPv2 pan-cancer AAC 0.096 0.002
mRNA thapsigargin gCSI pan-cancer AAC -0.17 0.002
mRNA TW 37 GDSC1000 pan-cancer AAC -0.1 0.002
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA BMS-345541 GDSC1000 pan-cancer AAC 0.093 0.003
mRNA AT13387 CTRPv2 pan-cancer AAC 0.14 0.003
Download CSV